Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
Chaves Filho AJM, Cunha NL, De Souza AG, et al
Ongoing clinical trials are investigating the long-term effects of GLP-1 medications on diabetic eye disease, with results expected to provide clearer guidance for both patients and healthcare providers
No recongelar una vez reconstituido los ciclos de congelacin-descongelacin degradan la integridad del pptido entre un 5 y un 15% por ciclo
Bioavailability and why it matters for frequency Injectable semaglutide achieves approximately 89% bioavailability
